Harvard Management Q4 2025: $2.08B 13F-HR with 12.78% in IBIT

Harvard Management Company — the in-house investment office that runs Harvard University's endowment — filed a 13F-HR for Q4 2025 disclosing $2.08B in long US equity positions across 19 names. That is not the entire endowment (Harvard's total endowment is over $50B and the bulk sits in private equity, hedge funds, real assets, and externally-managed mandates that don't appear on Form 13F). What it does represent is the segment of the book held in publicly-traded US securities that crosses the reporting threshold — and after eight quarters of effectively-empty filings, that segment now has shape.

The shape is striking: 12.78% in IBIT (BlackRock's spot Bitcoin ETF), 11.94% in GLD (the SPDR Gold Shares ETF), and the remaining 75% concentrated in a tight mega-cap equity core. Every single position is flagged as NEW in our QoQ delta — meaning none of the 19 names appeared on Harvard's prior 13F. This is either a clean restart of how the office reports US equity exposure, or a deliberate portfolio reposition. Either way, it is the first time in recent memory the public can see what Harvard's investment team is actually doing on the long-equity side.

The portfolio at a glance

The position-size ranking puts IBIT first, which is the headline. Harvard now holds 5.35M shares of IBIT worth $265.8M — effectively a single-instrument expression of a Bitcoin allocation. That is not a token position to satisfy a board mandate; at 12.78% of the disclosed book it is the largest line item. Pairing it with $248.3M of GLD at 11.94% is the giveaway on intent: this is not a tactical crypto bet, this is a paired non-correlated-asset hedge, sized in the same neighborhood as the largest equity name. An endowment with multi-decade liabilities and an inflation-protection mandate would build the book exactly this way.

The equity core: where the conviction is

Strip out IBIT and GLD and the remaining $1.57B is overwhelmingly mega-cap tech and consumer franchises:

The selection is unsurprising for an institutional book that wants megacap quality with secular AI exposure: GOOGL and MSFT within ~$16M of each other; AMZN, META, and AVGO filling out the AI-adjacent megacap stack; TSM as the semis-fab leg of the same trade. The two non-tech names — BKNG at 8.67% and UNP at 6.80% — are the more interesting picks. Booking is a high-margin cash-generative travel platform with a buyback overlay; Union Pacific is a regulated-monopoly railroad and a classic endowment-style infrastructure compounder. Both fit an "own quality moats" frame.

The concentration picture

This is a deeply concentrated book by 13F standards. The top-5 names sum to 56.94% of the disclosed value, and the top-10 to 86.92%. The 19-name footprint with no name below ~$5M and the top five all between $180M and $266M says the portfolio was sized deliberately — not allowed to drift as a residual of a broader fund-of-funds book. Whoever set the position sizes is treating each holding as a discrete capital allocation, not a market-cap-weighted basket.

That has implications. Concentration at this level is a behavior signal: the investment office is willing to take active sizing risk for the names it picks, which is unusual for an endowment that historically delegated most public-equity exposure to external active and passive managers. The presence of IBIT and GLD as 1st- and 3rd-largest positions reinforces the read: this is a deliberately-constructed account, not an index overlay.

The AUM history is the most interesting tell

The reported AUM history shows essentially-empty 13F filings from 2023Q3 through 2025Q3, with the most recent quarter jumping to $2.08B. The likeliest explanation is that prior quarters reflect a different reporting vehicle — possibly 13F-NT confidential treatment requests, or a different sub-entity within the Harvard Management complex — and that Q4 2025 represents the first quarter the public US-equity sleeve has been disclosed on the standard 13F-HR form. Confidential treatment for new positions is a common endowment tool: the SEC permits temporary non-disclosure for material new positions that the manager has not finished building. Once the build is complete (or the request expires after 12 months), the position becomes publicly visible.

If that read is correct — and the cleanness of all 19 positions being flagged "NEW" supports it — then what we are seeing is the disclosure of a build that may have happened over the trailing four quarters. The next two 13F filings will tell us whether the positions remain stable (consistent with a long-term allocation thesis), get trimmed (tactical post-build adjustment), or grow (the build wasn't finished).

What to watch from here

1. The 2026-Q1 13F (filing due May 15, 2026 — this window is open now). Compare position sizes against Q4 2025. Stable sizing confirms the strategic-allocation thesis; aggressive trimming of IBIT in particular would reframe the Q4 disclosure as a peak-of-build snapshot.
2. The Harvard Management Company FY annual report (typically published October each year). Look for explicit asset-allocation policy targets — specifically the long-equity sub-allocation. A formalized digital-asset allocation policy would lift IBIT from a tactical position to a permanent line item.
3. BTC and gold cross-correlations. The 12.78% / 11.94% pairing only works as a non-correlated hedge if the correlation stays low. A regime where both assets move together (as they briefly did in 2024) would invalidate the diversification thesis and likely trigger a trim of one.

FAQ

Why is Harvard Management's 13F-HR only $2.08B when the endowment is over $50B?

Form 13F only requires disclosure of long US-equity positions (and certain US-listed convertible debt, options, and ADRs) that cross the reporting threshold. The bulk of Harvard's $50B+ endowment sits in private equity, hedge funds, real estate, real assets, and externally-managed mandates that do not appear on 13F. The $2.08B disclosed in Q4 2025 represents the publicly-traded US equity sleeve held directly by Harvard Management.

Why are all 19 positions flagged as NEW?

The likeliest explanation is that prior quarters were filed under a different form (13F-NT confidential treatment, or a sub-entity within the Harvard Management complex) and Q4 2025 is the first public disclosure of the standard 13F-HR sleeve. Whether the positions were actually built in Q4 or were under confidential treatment from prior quarters cannot be determined from the public filing alone.

Is the 12.78% IBIT allocation typical for an endowment?

It is at the high end. Yale and Princeton have publicly discussed crypto via venture allocations rather than spot ETFs. Harvard's choice of IBIT (the spot Bitcoin ETF) rather than a venture-fund LP exposure is more liquid and easier to mark to market. Whether 12.78% is "normal" depends on whether Harvard treats it as an equity allocation (high) or an inflation-hedge bucket alongside GLD (more defensible).

When will the next 13F be filed?

The 2026-Q1 13F-HR filing window closes on May 15, 2026. Holdings will reflect the March 31, 2026 record date. Compare position sizes against Q4 2025 to read whether this was a one-shot disclosure or the start of a stable allocation.

For E-E-A-T citation, the underlying 13F-HR filing is publicly indexed on SEC EDGAR under Harvard Management's CIK 0001082621. The full position table, holder history, and live links to all 19 underlying stocks are available on Harvard Management's filer page. For readers comparing this disclosure against peer endowments, see also the research library and institutional signal feed.